Placebo effect and dopamine release

  • R. de la Fuente-Fernández
  • S. Lidstone
  • A. J. Stoessl
Part of the Journal of Neural Transmission. Supplementa book series (NEURALTRANS, volume 70)

Summary

The placebo effect can be encountered in a great variety of medical conditions, but is particularly prominent in pain, depression and Parkinson’s disease. It has been shown that placebo responses play a part in the effect of any type of treatment for Parkinson’s disease, including drug therapy, deep brain stimulation and dopamine tissue transplantation. Recent studies have demonstrated that the placebo effect in Parkinson’s disease is related to the release of substantial amounts of endogenous dopamine in both the dorsal and ventral striatum. As the ventral striatum is involved in reward processing, these observations suggest that the placebo effect may be linked to reward mechanisms. In keeping with this placebo-reward model, most recent experiments have shown activation of the reward circuitry in association with placebo responses in other disorders. In addition, as dopamine is the major neurotransmitter in the reward circuitry, the model predicts that the release of dopamine in the ventral striatum could be involved in mediating placebo responses not only in Parkinson’s but also in other medical conditions.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beecher HK (1955) The powerful placebo. JAMA 159: 1602–1606Google Scholar
  2. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7: 587–588PubMedCrossRefGoogle Scholar
  3. de la Fuente-Fernández R (2004) Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson’s disease. Parkinsonism Relat Disord 10: 125–127PubMedCrossRefGoogle Scholar
  4. de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ (2002a) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136: 359–363PubMedCrossRefGoogle Scholar
  5. de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 293: 1164–1166PubMedCrossRefGoogle Scholar
  6. de la Fuente-Fernández R, Schulzer M, Stoessl AJ (2002b) The placebo effect in neurological disorders. Lancet Neurol 1: 85–91PubMedCrossRefGoogle Scholar
  7. de la Fuente-Fernández R, Schulzer M, Stoessl AJ (2004) Placebo mechanisms and reward circuitry: clues from Parkinson’s disease. Biol Psychiatry 56: 67–71PubMedCrossRefGoogle Scholar
  8. Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 2: 654–657PubMedCrossRefGoogle Scholar
  9. Lidstone S, de la Fuente-Fernández R, Stoessl AJ (2005) The placebo response as a reward mechanism. Semin Pain Med 3: 37–42CrossRefGoogle Scholar
  10. McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR (2004) Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 61: 412–420PubMedCrossRefGoogle Scholar
  11. Schultz W (1998) Predictive reward signal and dopamine neurons. J Neurophysiol 80: 1–27PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • R. de la Fuente-Fernández
    • 1
  • S. Lidstone
    • 2
  • A. J. Stoessl
    • 2
  1. 1.Division of NeurologyHospital A. MarcideFerrolSpain
  2. 2.Pacific Parkinson’s Research CentreUBCVancouverCanada

Personalised recommendations